Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Patent was issued and finalized April 27 2021 for the Deltawave mask. A copy of the patent can easily be found.
Any other nonsense is false. There are no “new” patents.
Uplisting Press Release yesterday.
Otcqb status expected to be live tomorrow.
Remsleep released a tweet today informing investors that they have applied for trade mark on their DeltaWave!
More to come so stay tuned!
Remsleep Holdings Inc
@RemsleepInc
In anticipation of marketing and market protection, RemSleep’s trademark application for “DeltaWave” was filed with the United States Patent and Trademark Office on July 5, 2022. The USPTO has now assigned Trademark Serial No. 97489045 to the application. $RMSL
10:27 AM · Jul 13, 2022·Twitter for Androi
The Press Release yesterday finished with the Sentence “This is just the beginning so stay tuned.” Well I hope you are tuned in now. I didn’t see one person talking about trademark as a future catalyst or accomplishment.
Remsleep continues to surprise me with their open communication to investors and it’s very rare to find a growing company who recognizes they wouldn’t be were they are without their shareholders and investors.
Proud to be a part of something bigger then just money. Part of a team and part of a company that is going to make a major difference in effectively treating those with sleep apnea specifically those who suffer from COPD and Congestive Heart Failure.
Sometimes it’s about more then just money and when you find that hang on tight!
Guy claims Patent isn’t real is he gonna try and claim the uplisting isn’t real as well
RemSleep Holdings Inc. (OTC PINK: RMSL), a medical device manufacturer dedicated to forever changing the level of treatment provided to obstructive Sleep Apnea patients, announced today that the company has officially received approval to be uplisted to OTCQB® status with . We anticipate OTCQB® status to be live on within 24-48 hours of this press release. The move to the OTCQB® exchange provides enhanced investor benefits, including higher reporting standards, greater access to analyst coverage and news outlets, increased liquidity and stability, along with more comprehensive compliance requirements. The OTCQB® exchange is considered by the Securities and Exchange Commission (SEC) as an "established public market" for determining the public market price when registering securities for resale with the SEC. The OTC Pink is not considered as such, and because of this most broker dealers will not trade or recommend OTC Pink stocks. By gaining OTCQB® status, a company dramatically increases their transparency, reporting standards, and management certification and compliance requirements, therefore most broker dealers trade stocks on the OTCQB® exchange. Historically, companies that have made it to the OTCQB® tier have experienced increased investor awareness and greater liquidity and visibility of their common stock.
“This is a great milestone for RemSleep and our shareholders. We could not be more excited for where we are currently positioned and the trajectory of where we are going. Uplisting to OTCQB® status provides next level accountability from us as a company with higher reporting standards and more comprehensive compliance requirements. OTCQB® status will assist our company in providing greater shareholder value by allowing us to achieve greater market visibility, expand our potential prospective investor pool, greater share price stability, along with increased trading liquidity within the investment community. We look forward to broadening our company exposure to a larger and more diverse demographic of both domestic and international investors,” stated Tom Wood, RemSleep CEO.
Wood continued, “This is the first of many milestones we have in the works. We hope to provide an update in the next couple of weeks regarding our impending FDA 510k filing for our patented DeltaWave Nasal Pillow Mask, the filing of future 510k application(s) for our recently announced second CPAP mask that will include both a residential and hospital version, and our CPAP machine distribution deal progress. This is an exciting time for everyone involved in RemSleep as we transition from a pre-revenue OTC Pink company to a positive cash flow and profitable OTCQB® listed company. This is just the beginning so stay tuned.”
About RemSleep Holdings Inc.
www.remsleep.comRemSleep Holdings Inc. is a medical device manufacturer dedicated to forever changing the level of treatment provided to obstructive Sleep Apnea patients. Our focus is primarily designing and manufacturing devices and products for the treatment of Sleep Apnea and other respiratory conditions. With over 30 years of collective experience in CPAP therapy, the RemSleep team has extensive knowledge and understanding of CPAP and the challenges of patient compliance. We diligently strive for our products to make the difference and improve the condition of those suffering from Sleep Apnea.
https://twitter.com/RemsleepInc
Team Gaslighting: "20% percent is the same as 100%!"
Keep mentioning irrelevant information. There is a very real 20 year U.S. patent and uplisting is coming any day. Debt free positive cash flows!!!
The Deltawave is revolutionary and I personally use it… this is as legit a Company as you will find in the otc world!
True growth Company
Whoops meant for whsi board
Heavy what? Lol there is no volume at all… buy sell no trade data…
Very heavy buy volume today.This company didn't come this far to fail most people know this.
It hasn’t happened yet. The Conakry is working with a testing company TBA in order to get things completed properly to submit a new 510k application for the reclassification
Man I don’t know how much you get paid but you filed to acknowledge the mask is real and works…
The Os was increased to pay for FDA process and pay off debt…
Conveniently left out that the SP continues higher and that they have mentioned a second mask in their PRs
Losers will remain losers sadly… smh
Pump and dumps go up, then they go back down. The PPS is a product of social media pumping and nothing more.
The O/S is up a bit... from less than 200M shares to nearly 1.5B.
They've been puttering around with this 1 horribly designed mask for years, reverse merging in early 2015, pumping how that 1 mask was surely to make everyone rich soon, then whining about the latest "glitch" or setback. Fixing to get ready to prepare to possibly start selling that one mask has been the battle cry all along while they or the latest toxic lender sold stock.
The only thing they've sold is stock. The only thing they continue to build is a story.
SP is up 250% since your March 2020 post… sure OS is higher but debt was large back then and has been paid off now in full… they have significant inventory of the cpap machines they are selling as part of the distribution deal.
DeltaWave 510k approval from FDA is when the real revenue will start. They confirmed uplisting to otcqb and management is taking a very minimal paid salary.
Buyout has always been the end goal and they are progressing nicely towards that goal
Dude… the price is up 1700% since December 2020… they have a very real product that I own myself…
They have cash on hand from the offering and paid off all debts like a responsible company would.
Again go re read the recent Press Releases… they were a pretty revenue company… and are now revenue generating with positive cash flows… the revenues will show on the next 10q in august
Dude... I've been watching this company longer than you think... the only thing they've ever sold is a lot of stock.
From 2020
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=154462367
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=154521396
They have not said they are selling machines until this last quarter… smh
So yes the financials will not show the revenues because they haven’t been released yet for this quarter….
If you can read “financials” then try reading the press releases as well…
Debt free company and uplisting to the otc… yet people still try to find negatives smh
I couldn't care less what they say, I'm looking at their financial reports which show zero revenue for the last 4 years and through the last reporting quarter. They've been saying they're going to sell machines for a couple years, but haven't.
So, explain the claim "cash flow positive."
You realize they have revenue now with selling cpap machines….
Positive cashflows with zero revenue. That's quite a trick....
6 months through the year and while the rest of the market is deep red RMSL is up 101% Year to date and riding a 9 day green streak!
Debt free, positive cash flows, open communication from management, uplisting application confirmed and expected to be completed in 1-2 weeks…
Oh and there is a revolutionary Sleep mask called DeltaWave. What’s even bigger news is the company informing investors there is indeed a second mask that is even better then the DeltaWave.
Massive gains over the past 17 months and I expect similar returns over the next 17 months
They didn’t last long
FYI… the year is 2022… RMSL is making waves both financially for investors and for the future of sleep apnea treatment!
Feel free to do your own research… uplisting is coming soon and then the delta wave will get FDA approval!
Patent REJECTION PR 11/20/20...one day after the 510k rejection PR.
https://www.globenewswire.com/fr/news-release/2020/11/20/2131071/0/en/REMSleep-Patent-Application.html
Anybody can get a freebie from Tom, hook it up to a CPAP machine and say it's great. No one cares if it can't get clearance from the FDA for SEVEN YEARS and counting.
They can't sell one mask without the 510k clearance. All the five star pumper reviews in the world can't change that.
Considering the Deltawave has never actually been denied by the FDA you are reaching…. You just asked last month for a photo of it being used…
I use the Deltawave and it works amazing… no I’ll side effects!
Posting about FDA thinking something is amazing shows ZERO credibility… FDA’s job is not to judge the effectiveness or give a review on the medical device. Their job when giving 510k approval is to make sure a medical device is safe for consumer use.
FDA doesn't think the DeltaWave is "amazing" which is why the 510k hasn't been cleared in SEVEN years.
Freebie sample pump reviews don't contribute to the bottom line.
Followers
|
309
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
31338
|
Created
|
11/14/08
|
Type
|
Free
|
Moderators |
REMSleep Holdings, Inc. is engaged in the business of developing and distributing sleep apnea products. The Company focuses on offering optimum compliance and comfort for continuous positive airway pressure (CPAP) patients. Its DeltaWave CPAP interface (the DeltaWave) is a device to treat patients with sleep apnea. Its DeltaWave product is a nasal-pillows type interface that is designed with airflow characteristics to enable patients with sleep apnea to breathe normally. Its product is manufactured by mold makers. Its target market includes home care dealers, private sleep labs, product end users, sleep physicians, medical groups, sleep product distributors, hospitals, medical associations, such as the American academy of sleep medicine and the American sleep association. REMSleep LLC is its wholly owned subsidiary.
INDUSTRY
Medical Equipment & Supplies
CONTACT INFO
2202 N. WEST SHORE BLVD SUITE 200
TAMPA, FL
33607
United States
+1.912.5902001
https://www.remsleep.com/EXECUTIVE LEADERSHIP
Russell Finlay Bird
Chairman of the Board
Thomas J. Wood
Chief Executive Officer, Director
Jonathan B Lane
Chief Technology Officer, Vice President
https://www.fundable.com/remsleep
Share Structure
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |